Literature DB >> 21542587

Hexadentate terephthalamide(bis-hydroxypyridinone) ligands for uranyl chelation: structural and thermodynamic consequences of ligand variation.

Géza Szigethy1, Kenneth N Raymond.   

Abstract

Several linear, hexa- and tetradentate ligands incorporating a combination of 2,3-dihydroxy-terephthalamide (TAM) and hydroxypyridinone-amide (HOPO) moieties have been developed as uranyl chelating agents. Crystallographic analysis of several {UO(2)[TAM(HOPO)(2)]}(2-) complexes revealed a variable and crowded coordination geometry about the uranyl center. The TAM moiety dominates the bonding in hexadenate complexes, with linker rigidity dictating the equality of equatorial U-O bonding. Hexadentate TAM(HOPO)(2) ligands demonstrated slow binding kinetics with uranyl affinities on average 6 orders of magnitude greater than those of similarly linked bis-HOPO ligands. Study of tetradentate TAM(HOPO) ligands revealed that the high uranyl affinity stems primarily from the presence of the TAM moiety and only marginally from increased ligand denticity. Uranyl affinities of TAM(HOPO)(2) ligands were within experimental error, with TAM(o-phen-1,2-HOPO)(2) exhibiting the most consistent uranyl affinity at variable pH.

Entities:  

Year:  2011        PMID: 21542587     DOI: 10.1021/ja201511u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  6 in total

1.  Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for 230U Targeted α-Therapy.

Authors:  Joshua J Woods; Ryan Unnerstall; Abbie Hasson; Diane S Abou; Valery Radchenko; Daniel L J Thorek; Justin J Wilson
Journal:  Inorg Chem       Date:  2022-02-09       Impact factor: 5.436

2.  Harnessing α-Emitting Radionuclides for Therapy: Radiolabeling Method Review.

Authors:  Hua Yang; Justin J Wilson; Chris Orvig; Yawen Li; D Scott Wilbur; Caterina F Ramogida; Valery Radchenko; Paul Schaffer
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

3.  Structural elucidation and physicochemical properties of mononuclear Uranyl(VI) complexes incorporating dianionic units.

Authors:  Mohammad Azam; Gunasekaran Velmurugan; Saikh Mohammad Wabaidur; Agata Trzesowska-Kruszynska; Rafal Kruszynski; Saud I Al-Resayes; Zeid A Al-Othman; Ponnambalam Venuvanalingam
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

4.  Novel enterobactin analogues as potential therapeutic chelating agents: Synthesis, thermodynamic and antioxidant studies.

Authors:  Qingchun Zhang; Bo Jin; Zhaotao Shi; Xiaofang Wang; Qiangqiang Liu; Shan Lei; Rufang Peng
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

5.  A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo.

Authors:  Xiaomei Wang; Xing Dai; Cen Shi; Jianmei Wan; Mark A Silver; Linjuan Zhang; Lanhua Chen; Xuan Yi; Bizheng Chen; Duo Zhang; Kai Yang; Juan Diwu; Jianqiang Wang; Yujie Xu; Ruhong Zhou; Zhifang Chai; Shuao Wang
Journal:  Nat Commun       Date:  2019-06-25       Impact factor: 14.919

6.  Siderophore-inspired chelator hijacks uranium from aqueous medium.

Authors:  Alexander S Ivanov; Bernard F Parker; Zhicheng Zhang; Briana Aguila; Qi Sun; Shengqian Ma; Santa Jansone-Popova; John Arnold; Richard T Mayes; Sheng Dai; Vyacheslav S Bryantsev; Linfeng Rao; Ilja Popovs
Journal:  Nat Commun       Date:  2019-02-18       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.